Interleukin-1β, but not interleukin-6, enhances renal and systemic endothelin production in vivo

American Journal of Physiology - Renal Physiology

Volumn 295, Issue 2, 2008, Pages

  Boesen, Erika I ^a   Sasser, Jennifer M ^a   Saleh, Mohamed A ^a   Potter, William A ^a   Woods, Mandy ^b   Warner, Timothy D ^b   Pollock, Jennifer S ^a   Pollock, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Inflammatory cytokines; Mouse inner medullary collecting duct cell line; Nuclear factor B; Renal inflammatory conditions

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; 3-(4-METHYLPHENYLSULFONYL)-2-PROPENENITRILE; NITRILE; SULFONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXCRETION; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MICTURITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELEMETRY; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; KIDNEY MEDULLA; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; INTERLEUKIN-1BETA; INTERLEUKIN-6; KIDNEY MEDULLA; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; NITRILES; SULFONES;

EID: 52449126954     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00095.2008     Document Type: Article

References (57)

1. Abassi ZA, Tate JE, Golomb E, Keiser HR. Role of neutral endopeptidase in the metabolism of endothelin. Hypertension 20: 89-95, 1992.
2. Ahn D, Ge Y, Stricklett PK, Gill P, Taylor D, Hughes AK, Yanagisawa M, Miller L, Nelson RD, Kohan DE. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 114: 504-511, 2004.
3. Beasley D, Dinarello CA, Cannon JG. Interleukin-1 induces natriuresis in conscious rats: role of renal prostaglandins. Kidney Int 33: 1059-1065, 1988.
4. Breuiller-Fouche M, Moriniere C, Dallot E, Oger S, Rebourcet R, Cabrol D, Leroy MJ. Regulation of the endothelin/endothelin receptor system by interleukin-1β in human myometrial cells. Endocrinology 146: 4878-4886, 2005.
5. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 38: 399-403, 2001.
6. Corder R, Carrier M, Khan N, Klemm P, Vane JR. Cytokine regulation of endothelin-1 release from bovine aortic endothelial cells. J Cardiovasc Pharmacol 26 Suppl 3: S56-S58, 1995.
7. Dalekos GN, Elisaf M, Bairaktari E, Tsolas O, Siamopoulos KC. Increased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? J Lab Clin Med 129: 300-308, 1997.
8. Dhaun N, Goddard J, Webb DJ. The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol 17: 943-955, 2006.
9. Elmarakby AA, Loomis ED, Pollock JS, Pollock DM. NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 45: 283-287, 2005.
10. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99: 861-866, 1999.
11. Gariepy CE, Ohuchi T, Williams SC, Richardson JA, Yanagisawa M. Salt-sensitive hypertension in endothelin-B receptor-deficient rats. J Clin Invest 105: 925-933, 2000.
12. Gratton JP, Cournoyer G, Loffler BM, Sirois P, D'Orleans-Juste P. ETB receptor and nitric oxide synthase blockade induce BQ-123-sensitive pressor effects in the rabbit. Hypertension 30: 1204-1209, 1997.
13. Haq M, Norman J, Saba SR, Ramirez G, Rabb H. Role of IL-1 in renal ischemic reperfusion injury. J Am Soc Nephrol 9: 614-619, 1998.
14. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106: 506-512, 1999.
15. Hartner A, Cordasic N, Klanke B, Veelken R, Hilgers KF. Strain differences in the development of hypertension and glomerular lesions induced by deoxycorticosterone acetate salt in mice. Nephrol Dial Transplant 18: 1999-2004, 2003.
16. Herman WH, Holcomb JM, Hricik DE, Simonson MS. Interleukin-1β induces endothelin-1 gene by multiple mechanisms. Transplant Proc 31: 1412-1413, 1999.
17. Hocher B, Schwarz A, Reinbacher D, Jacobi J, Lun A, Priem F, Bauer C, Neumayer HH, Raschack M. Effects of endothelin receptor antagonists on the progression of diabetic nephropathy. Nephron 87: 161-169, 2001.
18. + absorption and stimulate anion secretion by IMCD cells. Am J Physiol Renal Physiol 275: F946-F954, 1998.
19. Ihling C, Bohrmann B, Schaefer HE, Technau-Ihling K, Loeffler BM. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis - novel targets for pharmacotherapy in atherosclerosis. Curr Vasc Pharmacol 2: 249-258, 2004.
20. Jo SK, Sung SA, Cho WY, Go KJ, Kim HK. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 21: 1231-1239, 2006.
21. Kahaleh MB, Fan PS. Effect of cytokines on the production of endothelin by endothelial cells. Clin Exp Rheumatol 15: 163-167, 1997.
22. Katoh M, Ohmachi Y, Kurosawa Y, Yoneda H, Tanaka N, Narita H. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice. Eur J Pharmacol 398: 381-387, 2000.
23. Kawana M, Lee ME, Quertermous EE, Quertermous T. Cooperative interaction of GATA-2 and AP1 regulates transcription of the endothelin-1 gene. Mol Cell Biol 15: 4225-4231, 1995.
24. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, Asano M, Moriwaki H, Seishima M. Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23: 656-660, 2003.
25. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52: 2784-2789, 2003.
26. Kohan DE. Endothelin synthesis by rabbit renal tubule cells. Am J Physiol Renal Fluid Electrolyte Physiol 261: F221-F226, 1991.
27. Lan HY, Nikolic-Paterson DJ, Zarama M, Vannice JL, Atkins RC. Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 43: 479-485, 1993.
28. Lee DL, Leite R, Fleming C, Pollock JS, Webb RC, Brands MW. Hypertensive response to acute stress is attenuated in interleukin-6 knockout mice. Hypertension 44: 259-263, 2004.
29. Lee DL, Sturgis LC, Labazi H, Osborne JB Jr, Fleming C, Pollock JS, Manhiani M, Imig JD, Brands MW. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 290: H935-H940, 2006.
30. Liu J, Mankani G, Shi X, Meyer M, Cunningham-Runddles S, Ma X, Sun ZS. The circadian clock Period 2 gene regulates γ-interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock. Infect Immun 74: 4750-4756, 2006.
31. Masotto C, Caspani G, De Simoni MG, Mengozzi M, Scatturin M, Sironi M, Carenzi A, Ghezzi P. Evidence for a different sensitivity to various central effects of interleukin-1β in mice. Brain Res Bull 28: 161-165, 1992.
32. Mortensen LH, Fink GD. Salt-dependency of endothelin-induced, chronic hypertension in conscious rats. Hypertension 19: 549-554, 1992.
33. Navarro JF, Milena FJ, Mora C, Leon C, Garcia J. Renal proinflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration. Am J Nephrol 26: 562-570, 2006.
34. Nowicki PT. IL-1β alters hemodynamics in newborn intestine: role of endothelin. Am J Physiol Gastrointest Liver Physiol 291: G404-G413, 2006.
35. Ohta K, Hirata Y, Imai T, Kanno K, Emori T, Shichiri M, Marumo F. Cytokine-induced release of endothelin-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun 169: 578-584, 1990.
36. Plata-Salaman CR, Oomura Y, Kai Y. Tumor necrosis factor and interleukin-1β: suppression of food intake by direct action in the central nervous system. Brain Res 448: 106-114, 1988.
37. Plata-Salaman CR, Sonti G, Borkoski JP, Wilson CD, French-Mullen JM. Anorexia induced by chronic central administration of cytokines at estimated pathophysiological concentrations. Physiol Behav 60: 867-875, 1996.
38. A receptor antagonists, candesartan, and A-127722 in DOCA-salt hypertensive rats. Gen Pharmacol 34: 337-342, 2000.
39. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334, 2001.
40. Qi Z, Fujita H, Jin J, Davis LS, Wang Y, Fogo AB, Breyer MD. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 54: 2628-2637, 2005.
41. Quehenberger P, Bierhaus A, Fasching P, Muellner C, Klevesath M, Hong M, Stier G, Sattler M, Schleicher E, Speiser W, Nawroth PP. Endothelin 1 transcription is controlled by nuclear factor-κB in AGE-stimulated cultured endothelial cells. Diabetes 49: 1561-1570, 2000.
42. Rauchman MI, Nigam SK, Delpire E, Gullans SR. An osmotically tolerant inner medullary collecting duct cell line from an SV40 transgenic mouse. Am J Physiol Renal Fluid Electrolyte Physiol 265: F416-F424, 1993.
43. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101: 1767-1772, 2000.
44. Sasser JM, Sullivan JC, Hobbs JL, Yamamoto T, Pollock DM, Carmines PK, Pollock JS. Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol 18: 143-154, 2007.
45. B receptors in cardiovascular disease. Annu Rev Pharmacol Toxicol 47: 731-759, 2007.
46. Sheryanna A, Bhangal G, McDaid J, Smith J, Manning A, Foxwell BM, Feldmann M, Cook HT, Pusey CD, Tam FW. Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1β or IL-6. J Am Soc Nephrol 18: 1167-1179, 2007.
47. Shikano M, Sobajima H, Yoshikawa H, Toba T, Kushimoto H, Katsumata H, Tomita M, Kawashima S. Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 85: 81-85, 2000.
48. Simonson MS, Emancipator SN, Knauss T, Hricik DE. Elevated neointimal endothelin-1 in transplantation-associated arteriosclerosis of renal allograft recipients. Kidney Int 54: 960-971, 1998.
49. Tzoulaki I, Murray GD, Lee AJ, Rumley A, Lowe GD, Fowkes FG. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation 112: 976-983, 2005.
50. Ujiie K, Terada Y, Nonoguchi H, Shinohara M, Tomita K, Marumo F. Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments. J Clin Invest 90: 1043-1048, 1992.
51. Volpato S, Guralnik JM, Ferrucci L, Balfour J, Chaves P, Fried LP, Harris TB. Cardiovascular disease, interleukin-6, and risk of mortality in older women: The Women's Health and Aging Study. Circulation 103: 947-953, 2001.
52. Waehre T, Yndestad A, Smith C, Haug T, Tunheim SH, Gullestad L, Froland SS, Semb AG, Aukrust P, Damas JK. Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. Circulation 109: 1966-1972, 2004.
53. Wetmore JB, Hung AM, Lovett DH, Sen S, Quershy O, Johansen KL. Interleukin-1 gene cluster polymorphisms predict risk of ESRD. Kidney Int 68: 278-284, 2005.
54. Wilhelm SM, Simonson MS, Robinson AV, Stowe NT, Schulak JA. Endothelin up-regulation and localization following renal ischemia and reperfusion. Kidney Int 55: 1011-1018, 1999.
55. Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 166: 324-329, 1990.
56. 2. Am J Physiol Renal Fluid Electrolyte Physiol 261: F1013-F1016, 1991.
57. Zhang Y, Adner M, Cardell LO. Interleukin-1β attenuates endothelin B receptor-mediated airway contractions in a murine in vitro model of asthma: roles of endothelin-converting enzyme and mitogen-activated protein kinase pathways. Clin Exp Allergy 34: 1480-1487, 2004.